Type 2 diabetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: Control group: People in this group will consume a 150-gram portion of normal low-fat yogurt daily for 8 weeks, before lunch. Yogurt will be supplied by Zarin Ghazal (Daiti) Company of
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age range from 20 to 60 years Body mass index between 25 -35 kg/m2 If taking medication to control blood sugar and lipid profile, a fixed-dose medication during the entire intervention Desire to cooperate
Exclusion criteria
Exclusion criteria: Participation in weight loss programs during the last 6 months (weight loss less than 10% in the last 6 months) Change in physical activity during the past 4 weeks Taking drugs that affect appetite and body weight or have an anti-inflammatory effect. Taking antioxidants or multivitamins and any type of food supplement in the last 3 months Pregnancy or breastfeeding Gastrointestinal surgery or weight loss (bariatric) surgery Smoking cessation in the last 6 months Kidney disease History of recurrent kidney stones Liver dysfunction Untreated hypertension History or symptoms of gallstones Cancer History of endocrine disorders (especially hypothyroidism) History of bulimia and/or laxative abuse Mental disorders or impaired independence History of alcohol or other drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: InBody scale and body analyzer.;Fasting blood sugar. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Laboratory test.;Glycosylated blood sugar (HbA1c). Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Laboratory test.;Waist circumference. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Inflexible meter - the measurement between the iliac crest and the last rib in the standing position.;Hip circumference. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Inflexible meter - the measurement of the circumference of the hips from the most prominent point of the hips in a standing position.;Body composition. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: InBody Body Analyzer (BIA).;Lipid profile. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Laboratory test.;Malondialdehyde (MDA). Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Laboratory test.;Serum Adiponectin. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Laboratory test.;Serum Leptin. Timepoint: At the beginning of the study and after 60 days of using the product. Method of measurement: Laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Jafar Dehzad
Shiraz University of Medical Sciences
Outcome results
None listed